[
1. Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of Plaque Formation and Rupture. Circ Res. 2014;114:1852-1866.10.1161/CIRCRESAHA.114.302721
]Search in Google Scholar
[
2. Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. The Lancet. 2017;389:197-210.10.1016/S0140-6736(16)30677-8
]Search in Google Scholar
[
3. Mitra N, Hodas R, Szabó E, Parajkó Z, Benedek T, Benedek I. Impact of Coronary Plaque Vulnerability on Acute Cardiovascular Events – Design of a CT-based 2-year Follow-up Study. Journal of Interdisciplinary Medicine. 2019;4:64-71.10.2478/jim-2019-0015
]Search in Google Scholar
[
4. Braunwald E. Epilogue: What Do Clinicians Expect From Imagers? J Am Coll Cardiol. 2006;47:C101-C103.10.1016/j.jacc.2005.10.07216631504
]Search in Google Scholar
[
5. Benedek T, Maurovich-Horváth P, Ferdinandy P, Merkely B. The Use of Biomarkers for the Early Detection of Vulnerable Atherosclerotic Plaques and Vulnerable Patients. A Review. Journal of Cardiovascular Emergencies. 2016;2:106-113.10.1515/jce-2016-0017
]Search in Google Scholar
[
6. Choi SY, Mintz GS. What Have We Learned About Plaque Rupture in Acute Coronary Syndromes? Curr Cardiol Rep. 2010;12:338-343.10.1007/s11886-010-0113-x
]Search in Google Scholar
[
7. Stefanadis C, Antoniou C, Tsiachris D, Pietri P. Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives. J Am Heart Assoc. 2017;6.10.1161/JAHA.117.005543552404428314799
]Search in Google Scholar
[
8. Brown AJ, Teng Z, Evans PC, Gillard JH, Samady H, Bennett MR. Role of biomechanical forces in the natural history of coronary atherosclerosis. Nat Rev Cardiol. 2016;13:210-220.10.1038/nrcardio.2015.20326822720
]Search in Google Scholar
[
9. Schaar J. Terminology for high-risk and vulnerable coronary artery plaques. Eur Heart J. 2004;25:1077-1082.10.1016/j.ehj.2004.01.00215191780
]Search in Google Scholar
[
10. Davies MJ. Coronary disease: the pathophysiology of acute coronary syndromes. Heart. 2000;83:361-366.10.1136/heart.83.3.361172933410677422
]Search in Google Scholar
[
11. Bentzon JF, Falk E. Atherosclerosis, Vulnerable Plaques, and Acute Coronary Syndromes. In: Genomic and Personalized Medicine. Elsevier, 2013; p. 530-539.10.1016/B978-0-12-382227-7.00047-1
]Search in Google Scholar
[
12. Nyulas T, Chiţu M, Mester A, et al. Computed Tomography Biomarkers of Vulnerable Coronary Plaques. Journal of Interdisciplinary Medicine. 2016;1:263-266.10.1515/jim-2016-0068
]Search in Google Scholar
[
13. Andreou I, Antoniadis AP, Shishido K, et al. How Do We Prevent the Vulnerable Atherosclerotic Plaque From Rupturing? Insights From In Vivo Assessments of Plaque, Vascular Remodeling, and Local Endothelial Shear Stress. J Cardiovasc Pharmacol Ther. 2015;20:261-275.10.1177/1074248414555005
]Search in Google Scholar
[
14. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of Vulnerable/Unstable Plaque. Arterioscler Thromb Vasc Biol. 2010;30:1282-1292.10.1161/ATVBAHA.108.179739
]Search in Google Scholar
[
15. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2010;10:36-46.10.1038/nri2675
]Search in Google Scholar
[
16. Gertz SD, Roberts WC. Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol. 1990;66:1368-1372.10.1016/0002-9149(90)91170-B
]Search in Google Scholar
[
17. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275.10.1161/01.ATV.20.5.1262
]Search in Google Scholar
[
18. Falk E, Shah PK, Fuster V. Coronary Plaque Disruption. Circulation. 1995;92:657-671.10.1161/01.CIR.92.3.657
]Search in Google Scholar
[
19. Falk E. Pathogenesis of Atherosclerosis. J Am Coll Cardiol. 2006;47:C7-C12.10.1016/j.jacc.2005.09.068
]Search in Google Scholar
[
20. Fleg JL, Stone GW, Fayad ZA, et al. Detection of High-Risk Atherosclerotic Plaque. JACC Cardiovasc Imaging. 2012;5:941-955.10.1016/j.jcmg.2012.07.007
]Search in Google Scholar
[
21. Wang X, Connolly TM. Biomarkers of Vulnerable Atheromatous Plaques. In: Advances in Clinical Chemistry. Vol 50. Elsevier, 2010; p. 1-22.10.1016/S0065-2423(10)50001-5
]Search in Google Scholar
[
22. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276-1282.10.1056/NEJM1997050133618029113930
]Search in Google Scholar
[
23. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89-95.10.1067/mcp.2001.11398911240971
]Search in Google Scholar
[
24. Feuerstein GZ, Chavez J. Translational Medicine for Stroke Drug Discovery: The Pharmaceutical Industry Perspective. Stroke. 2009;40:S121-S125.10.1161/STROKEAHA.108.53510419064772
]Search in Google Scholar
[
25. Mayeux R. Biomarkers: Potential uses and limitations. NeuroRX. 2004;1:182-188.10.1602/neurorx.1.2.18253492315717018
]Search in Google Scholar
[
26. Wang J, Balu N, Canton G, Yuan C. Imaging biomarkers of cardiovascular disease. J Magn Reson Imaging. 2010;32:502-515.10.1002/jmri.22266293530920815049
]Search in Google Scholar
[
27. Casscells W, Naghavi M, Willerson JT. Vulnerable Atherosclerotic Plaque: A Multifocal Disease. Circulation. 2003;107:2072-2075.10.1161/01.CIR.0000069329.70061.6812719287
]Search in Google Scholar
[
28. Fayad ZA, Fuster V. Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque. Circ Res. 2001;89:305-316.10.1161/hh1601.09559611509446
]Search in Google Scholar
[
29. Crouse JR. Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art. J Lipid Res. 2006;47:1677-1699.10.1194/jlr.R600012-JLR20016705212
]Search in Google Scholar
[
30. Nahrendorf M, Jaffer FA, Kelly KA, et al. Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis. Circulation. 2006;114:1504-1511.10.1161/CIRCULATIONAHA.106.64638017000904
]Search in Google Scholar
[
31. Jaffer FA, Libby P, Weissleder R. Optical and Multimodality Molecular Imaging: Insights Into Atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1017-1024.10.1161/ATVBAHA.108.165530273322819359659
]Search in Google Scholar
[
32. Tarkin JM, Dweck MR, Evans NR, et al. Imaging Atherosclerosis. Circ Res. 2016;118:750-769.10.1161/CIRCRESAHA.115.306247
]Search in Google Scholar
[
33. Burgstahler C, Reimann A, Beck T, et al. Influence of a Lipid-Lowering Therapy on Calcified and Noncalcified Coronary Plaques Monitored by Multislice Detector Computed Tomography: Results of the New Age II Pilot Study. Invest Radiol. 2007;42:189-195.10.1097/01.rli.0000254408.96355.85
]Search in Google Scholar
[
34. Sarno G, Decraemer I, Vanhoenacker PK, et al. On the Inappropriateness of Noninvasive Multidetector Computed Tomography Coronary Angiography to Trigger Coronary Revascularization. JACC Cardiovasc Interv. 2009;2:550-557.10.1016/j.jcin.2009.03.009
]Search in Google Scholar
[
35. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary Calcification, Coronary Disease Risk Factors, C-Reactive Protein, and Atherosclerotic Cardiovascular Disease Events. J Am Coll Cardiol. 2005;46:158-165.10.1016/j.jacc.2005.02.088
]Search in Google Scholar
[
36. Tardif JC, Lesage F, Harel F, Romeo P, Pressacco J. Imaging Biomarkers in Atherosclerosis Trials. Circ Cardiovasc Imaging. 2011;4:319-333.10.1161/CIRCIMAGING.110.962001
]Search in Google Scholar
[
37. Adamson PD, Newby DE. Non-invasive imaging of the coronary arteries. Eur Heart J. 2019;40:2444-2454.10.1093/eurheartj/ehy670
]Search in Google Scholar
[
38. Schroeder S, Kopp AF, Baumbach A, et al. Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography. J Am Coll Cardiol. 2001;37:1430-1435.10.1016/S0735-1097(01)01115-9
]Search in Google Scholar
[
39. Motoyama S, Kondo T, Sarai M, et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol. 2007;50:319-326.10.1016/j.jacc.2007.03.04417659199
]Search in Google Scholar
[
40. Lindsay AC, Choudhury RP. Form to function: current and future roles for atherosclerosis imaging in drug development. Nat Rev Drug Discov. 2008;7:517-529.10.1038/nrd258818483481
]Search in Google Scholar
[
41. Amirbekian V, Lipinski MJ, Briley-Saebo KC, et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci. 2007;104:961-966.10.1073/pnas.0606281104176633417215360
]Search in Google Scholar
[
42. McAteer MA, Schneider JE, Ali ZA, et al. Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide. Arterioscler Thromb Vasc Biol. 2008;28:77-83.10.1161/ATVBAHA.107.145466348178317962629
]Search in Google Scholar
[
43. Mitsumori LM, Hatsukami TS, Ferguson MS, Kerwin WS, Cai J, Yuan C. In vivo accuracy of multisequence MR imaging for identifying unstable fibrous caps in advanced human carotid plaques. J Magn Reson Imaging. 2003;17:410-420.10.1002/jmri.1026412655579
]Search in Google Scholar
[
44. Botnar RM, Buecker A, Wiethoff AJ, et al. In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent. Circulation. 2004;110:1463-1466.10.1161/01.CIR.0000134960.31304.8715238457
]Search in Google Scholar
[
45. Winter PM, Neubauer AM, Caruthers SD, et al. Endothelial α ν β 3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26:2103-2109.10.1161/01.ATV.0000235724.11299.7616825592
]Search in Google Scholar
[
46. Motoyama S, Sarai M, Harigaya H, et al. Computed Tomographic Angiography Characteristics of Atherosclerotic Plaques Subsequently Resulting in Acute Coronary Syndrome. J Am Coll Cardiol. 2009;54:49-57.10.1016/j.jacc.2009.02.06819555840
]Search in Google Scholar
[
47. Rudd JHF, Warburton EA, Fryer TD, et al. Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography. Circulation. 2002;105:2708-2711.10.1161/01.CIR.0000020548.60110.7612057982
]Search in Google Scholar
[
48. Tawakol A, Migrino R, Hoffmann U, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol. 2005;12:294-301.10.1016/j.nuclcard.2005.03.00215944534
]Search in Google Scholar
[
49. Wu YW, Kao HL, Huang CL, et al. The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. Eur J Nucl Med Mol Imaging. 2012;39:399-407.10.1007/s00259-011-1994-722109668
]Search in Google Scholar
[
50. Figueroa AL, Subramanian SS, Cury RC, et al. Distribution of Inflammation Within Carotid Atherosclerotic Plaques With High-Risk Morphological Features: A Comparison Between Positron Emission Tomography Activity, Plaque Morphology, and Histopathology. Circ Cardiovasc Imaging. 2012;5:69-77.10.1161/CIRCIMAGING.110.95947822038986
]Search in Google Scholar
[
51. Ishii H, Nishio M, Takahashi H, et al. Comparison of Atorvastatin 5 and 20 mg/d for Reducing F-18 Fluorodeoxyglucose Uptake in Atherosclerotic Plaques on Positron Emission Tomography/Computed Tomography: A Randomized, Investigator-Blinded, Open-Label, 6-Month Study in Japanese Adults Scheduled for Percutaneous Coronary Intervention. Clin Ther. 2010;32:2337-2347.10.1016/j.clinthera.2010.12.00121353104
]Search in Google Scholar
[
52. Sanz J, Fayad ZA. Imaging of atherosclerotic cardiovascular disease. Nature. 2008;451:953-957.10.1038/nature0680318288186
]Search in Google Scholar
